Redmile Group, LLC

Q2 2021 13F Holdings Report, Stock Holdings

Signature - Title
Jennifer Ciresi - General Counsel and Chief Compliance Officer
Location
San Francisco, CA
Holdings as of
June 30, 2021
Value $
$6.76B
Num holdings
86
Date filed
8/16/2021, 05:00 PM
Description
All US holdings of this investor are reported in this report. The Form 13F report requires disclosure of the manager that files the report, the name and class of the security, the CUSIP code, the number of shares as of the end of the calendar quarter for which the report is filed, and the total market value. The market value column should not be used as a substitute for Assets Under Management (AUM), as it does not include cash held in accounts.
Previous filing
Q1 2021 - May 17, 2021
Next filing
Q3 2021 - Nov 15, 2021
Sym Weight Trade Impact Company Class Shares Change Activity Value Change $ Value $ * Price $ Shares Principal
Filing 2021 Q2 compared to 2021 Q1 by default.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Rachel Chang Chief Compliance Officer San Francisco, California 8/16/2021

The attached information table excludes 972 shares of common stock of IGM BIOSCIENCES INC issued pursuant to restricted stock units.